Brown, Lisle/Cummings, Inc. Bristol Myers Squibb CO Call Options Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,444Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.4 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.85 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.1 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.16 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.29 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...